
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
Colorectal cancer (CRC) is the most common gastrointestinal cancer in developed and developing countries. In Iraq, it ranks the fifth among males accounting for 6.33% of total, and the fourth among females accounting for 4.35% of total according to Iraqi cancer Registry 2018. The depth of invasion of colorectal cancer through the bowel wall had provided the basis for pathological staging. However valuable this is, it is known that the distribution of patients to stage A, B or C of disease carries uncertain estimation of prognosis, and this has become controversial following the extensive acceptance of adjuvant chemotherapy, as it is now important to identify as precisely as possible those patients who despite a complete surgical clearance of the primary tumor will develop recurrent or distant disease. The establishment of prognostic markers for CRC is important in the search for potential targets for therapeutic intervention. This study aims to assess the expression of four of those markers; Cathepsin D, Galectin-3, wild and mutant BRAF in colorectal cancer using tissue microarray- immunohistochemistry (TMA- IHC) technique.
This study investigates the expression of specific biomarkers in Iraqi patients diagnosed with colorectal tumors to improve prognostic accuracy and identify potential therapeutic targets. The research addresses the limitations of current pathological staging in predicting patient outcomes for colorectal cancer (CRC), which ranks highly in Iraq. By employing the tissue microarray-immunohistochemistry (TMA-IHC) technique, the study aims to precisely assess the presence and distribution of Cathepsin D, Galectin-3, wild-type BRAF, and the BRAF V600E mutation in colorectal tumor tissues.
This research contributes to the ongoing effort to establish reliable prognostic markers for colorectal cancer, a significant health concern in Iraq. By focusing on specific biomarkers like Cathepsin D, Galectin-3, and BRAF mutations, the study aims to enhance the precision of patient stratification for treatment decisions. The methodology, utilizing TMA-IHC, is a standard approach for biomarker analysis in oncology research. The findings are expected to provide valuable insights into the molecular landscape of colorectal tumors within the Iraqi population.
Page Count:
264
Publication Date:
2019-08-06
Publisher:
LAP LAMBERT Academic Publishing
ISBN-10:
3659521884
ISBN-13:
9783659521881
No comments yet. Be the first to share your thoughts!